Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience

Aref Al-Kali; Ahmed Kamel Abou Hussein; Mrinal M Patnaik; Darci Zblewski; Naseema Gangat; Shahrukh Hashmi; Michelle Elliott; William Hogan; Mark R Litzow

doi:10.1080/10428194.2018.1436705

Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience

Aref Al-Kali, Ahmed Kamel Abou Hussein, Mrinal M Patnaik, Darci Zblewski, Naseema Gangat, Shahrukh Hashmi, Michelle Elliott, William Hogan, Mark R Litzow

Hematology

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	1-3
Number of pages	3
Journal	Leukemia and Lymphoma
DOIs	https://doi.org/10.1080/10428194.2018.1436705
State	Accepted/In press - Feb 22 2018

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1080/10428194.2018.1436705

Cite this

@article{408655dcd0c9410098eb47243f361a17,

title = "Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience",

author = "Aref Al-Kali and {Abou Hussein}, {Ahmed Kamel} and Patnaik, {Mrinal M} and Darci Zblewski and Naseema Gangat and Shahrukh Hashmi and Michelle Elliott and William Hogan and Litzow, {Mark R}",

year = "2018",

month = feb,

day = "22",

doi = "10.1080/10428194.2018.1436705",

language = "English (US)",

pages = "1--3",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U)

T2 - single institution experience

AU - Al-Kali, Aref

AU - Abou Hussein, Ahmed Kamel

AU - Patnaik, Mrinal M

AU - Zblewski, Darci

AU - Gangat, Naseema

AU - Hashmi, Shahrukh

AU - Elliott, Michelle

AU - Hogan, William

AU - Litzow, Mark R

PY - 2018/2/22

Y1 - 2018/2/22

UR - http://www.scopus.com/inward/record.url?scp=85042212191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042212191&partnerID=8YFLogxK

U2 - 10.1080/10428194.2018.1436705

DO - 10.1080/10428194.2018.1436705

M3 - Article

C2 - 29465270

AN - SCOPUS:85042212191

SN - 1042-8194

SP - 1

EP - 3

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

ER -

Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this